Announcements Trials
Browse Landscape

Phase

Phase 2 59Phase 1/2 11Phase 1 6Phase 3 4Phase NA 3Phase 4 3Phase 2/3 2

Status

Completed 31Recruiting 25Active not recruiting 20Terminated 8Not yet recruiting 5Unknown 4Withdrawn 1Suspended 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1

Conditions

Pancreatic Neoplasms 2Thromboembolism 1First-line Treatment of Advanced Pancreatic Cancer 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 130Radiotherapy 94Carboplatin 85Fluorouracil 79Paclitaxel 78Cyclophosphamide 77Gemcitabine 72Capecitabine 66Docetaxel 65Doxorubicin 60Oxaliplatin 59Etoposide 57Leucovorin 50Vincristine 47Chemotherapy, Adjuvant 42Cytarabine 38Dexamethasone 35Drug Therapy 33Bevacizumab 31Epirubicin 29Neoadjuvant Therapy 28Pemetrexed 27Tamoxifen 25Irinotecan 25Prednisone 24Rituximab 21Methotrexate 21Radiotherapy, Intensity-Modulated 19apatinib 18Vinorelbine 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Unknown × 130-nm albumin-bound paclitaxel × Clear all
NCT05751850 2024-05-09

HR070803 in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Advanced Pancreatic Cancer

Jiangsu HengRui Medicine Co., Ltd.

Phase 3 Unknown
778 enrolled
Gastrointestinal

First-line Treatment of Advanced Pancreatic Cancer

NCT05178628 2022-03-29

imPaCT-PRO

Institute of Molecular Medicine and Biomedical Research

Phase 3 Unknown
450 enrolled
Gastrointestinal

Pancreatic Neoplasms, Thromboembolism

NCT03262948 2017-11-13

Nab-Paclitaxel Versus Paclitaxel Plus Carboplatin in Advanced Squamous Cell Non Small Cell Lung Cancer

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 3 Unknown
388 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02506842 2016-08-11

Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection

Fudan University

Phase 3 Unknown
300 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡